Aft RL - Search Results

1

Chemosensitizing and cytotoxic effects of 2-deoxy-D-glucose on breast cancer cells.

Zhang F, Aft RL. Zhang F, et al. Among authors: aft rl. J Cancer Res Ther. 2009 Sep;5 Suppl 1:S41-3. doi: 10.4103/0973-1482.55140. J Cancer Res Ther. 2009. PMID: 20009293 Free article.

2

Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death.

Aft RL, Zhang FW, Gius D. Aft RL, et al. Br J Cancer. 2002 Sep 23;87(7):805-12. doi: 10.1038/sj.bjc.6600547. Br J Cancer. 2002. PMID: 12232767 Free PMC article.

3

2-Deoxy-D-glucose-induced cytotoxicity and radiosensitization in tumor cells is mediated via disruptions in thiol metabolism.

Lin X, Zhang F, Bradbury CM, Kaushal A, Li L, Spitz DR, Aft RL, Gius D. Lin X, et al. Among authors: aft rl. Cancer Res. 2003 Jun 15;63(12):3413-7. Cancer Res. 2003. PMID: 12810678

4

Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.

Aft RL, Lewis JS, Zhang F, Kim J, Welch MJ. Aft RL, et al. Cancer Res. 2003 Sep 1;63(17):5496-504. Cancer Res. 2003. PMID: 14500386

5

Metastatic disease to the breast: the Washington University experience.

Vaughan A, Dietz JR, Moley JF, Debenedetti MK, Aft RL, Gillanders WE, Eberlein TJ, Ritter J, Margenthaler JA. Vaughan A, et al. Among authors: aft rl. World J Surg Oncol. 2007 Jul 5;5:74. doi: 10.1186/1477-7819-5-74. World J Surg Oncol. 2007. PMID: 17615059 Free PMC article.

6

Racial disparities in the development of breast cancer metastases among older women: a multilevel study.

Schootman M, Jeffe DB, Gillanders WE, Aft R. Schootman M, et al. Cancer. 2009 Feb 15;115(4):731-40. doi: 10.1002/cncr.24087. Cancer. 2009. PMID: 19130463 Free PMC article.

7

Predictors of complete pathological response after neoadjuvant systemic therapy for breast cancer.

Tan MC, Al Mushawah F, Gao F, Aft RL, Gillanders WE, Eberlein TJ, Margenthaler JA. Tan MC, et al. Among authors: aft rl. Am J Surg. 2009 Oct;198(4):520-5. doi: 10.1016/j.amjsurg.2009.06.004. Am J Surg. 2009. PMID: 19800460 Free PMC article.

8

A gene expression signature that predicts the therapeutic response of the basal-like breast cancer to neoadjuvant chemotherapy.

Lin Y, Lin S, Watson M, Trinkaus KM, Kuo S, Naughton MJ, Weilbaecher K, Fleming TP, Aft RL. Lin Y, et al. Among authors: aft rl. Breast Cancer Res Treat. 2010 Oct;123(3):691-9. doi: 10.1007/s10549-009-0664-y. Epub 2009 Dec 6. Breast Cancer Res Treat. 2010. PMID: 19967557 Free PMC article.

9

Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models.

Ma CX, Cai S, Li S, Ryan CE, Guo Z, Schaiff WT, Lin L, Hoog J, Goiffon RJ, Prat A, Aft RL, Ellis MJ, Piwnica-Worms H. Ma CX, et al. Among authors: aft rl. J Clin Invest. 2012 Apr;122(4):1541-52. doi: 10.1172/JCI58765. Epub 2012 Mar 26. J Clin Invest. 2012. PMID: 22446188 Free PMC article.

10

Detection of disseminated tumor cells in the bone marrow of breast cancer patients using multiplex gene expression measurements identifies new therapeutic targets in patients at high risk for the development of metastatic disease.

Siddappa CM, Watson MA, Pillai SG, Trinkaus K, Fleming T, Aft R. Siddappa CM, et al. Breast Cancer Res Treat. 2013 Jan;137(1):45-56. doi: 10.1007/s10549-012-2279-y. Epub 2012 Nov 6. Breast Cancer Res Treat. 2013. PMID: 23129172 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

126 results

Search Page